1
|
Christon LM, Smith PJ. Psychosocial Evaluation for Lung Transplantation: an Empirically Informed Update. CURRENT TRANSPLANTATION REPORTS 2022. [DOI: 10.1007/s40472-022-00360-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
2
|
Karnatovskaia LV, Johnson MM, Varga K, Highfield JA, Wolfrom BD, Philbrick KL, Ely EW, Jackson JC, Gajic O, Ahmad SR, Niven AS. Stress and Fear: Clinical Implications for Providers and Patients (in the Time of COVID-19 and Beyond). Mayo Clin Proc 2020; 95:2487-2498. [PMID: 33153636 PMCID: PMC7606075 DOI: 10.1016/j.mayocp.2020.08.028] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 08/13/2020] [Accepted: 08/25/2020] [Indexed: 12/27/2022]
Abstract
In light of the coronavirus disease 2019 pandemic, we explore the role of stress, fear, and the impact of positive and negative emotions on health and disease. We then introduce strategies to help mitigate stress within the health care team, and provide a rationale for their efficacy. Additionally, we identify strategies to optimize patient care and explain their heightened importance in today's environment.
Collapse
Affiliation(s)
| | | | - Katalin Varga
- Affective Psychology Department, Eötvös Loránd University, Budapest, Hungary
| | - Julie A Highfield
- Department of Clinical Psychology in Critical Care, University Hospital Wales, Cardiff, UK
| | - Brent D Wolfrom
- Department of Family Medicine, Queen's University, Kingston, Canada
| | | | - E Wesley Ely
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center, Vanderbilt University Medical Center, Nashville, TN; Geriatric Research, Education and Clinical Center (GRECC), Tennessee Valley Veterans Affairs Healthcare System, Nashville, TN
| | - James C Jackson
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
| | | | | | | |
Collapse
|
3
|
Bui YT, Hathcock MA, Benzo RP, Budev MM, Chandrashekaran S, Erasmus DB, Lease ED, Levine DJ, Thompson KL, Johnson BK, Jowsey-Gregoire SG, Kennedy CC. Evaluating resilience as a predictor of outcomes in lung transplant candidates. Clin Transplant 2020; 34:e14056. [PMID: 32748982 DOI: 10.1111/ctr.14056] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 07/14/2020] [Accepted: 07/27/2020] [Indexed: 11/27/2022]
Abstract
BACKGROUND Resilience represents the capacity to adapt to adversity. Resilience can improve following behavioral interventions. We examined lung transplant candidates' resilience as a novel predictor using the Connor-Davidson Resilience Scale (RISC-10). METHODS Waitlisted candidates at six centers were mailed questionnaires from 9/16/2015 to 10/1/2019. Follow-up surveys were collected annually and post-transplant. Outcomes were recorded through February 17, 2020. Primary outcome was pre-transplant death/delisting. Analyses included t test or chi-square for group comparisons, Pearson's correlation coefficients for strength of relationships, and Cox proportional-hazard models to evaluate associations with outcomes, adjusting for age, sex, and mood. RESULTS Participation was 55.3% (N = 199). Baseline RISC-10 averaged 32.0 ± 5.6 and did not differ by demographics, primary transplant diagnosis, or disease severity markers. RISC-10 did not correlate to the commonly utilized Psychosocial Assessment of Candidates for Transplant [PACT] or Stanford Integrated Psychosocial Assessment for Transplantation [SIPAT] tools. Scores < 26.3 (representing > 1 standard deviation below population average) occurred in 16% and were associated with pre-transplant death or delisting, adjusted Hazard Ratio of 2.60 (95% Confidence Interval 1.23-5.77; P = .01). CONCLUSION One in six lung candidates had low resilience, predicting increased pre-transplant death/delisting. RISC-10 did not correlate with PACT or SIPAT; resilience may represent a novel risk factor.
Collapse
Affiliation(s)
- Yvonne Tran Bui
- Mayo Clinic Alix School of Medicine, Rochester, Minnesota, USA
| | - Matthew A Hathcock
- Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA
| | - Roberto P Benzo
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | - Marie M Budev
- Division of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
| | - Satish Chandrashekaran
- Division of Pulmonary, Critical Care & Sleep Medicine, University of Florida, Gainesville, Florida, USA
| | - David B Erasmus
- Transplant Medicine, Mayo Clinic, Jacksonville, Florida, USA
| | - Erika D Lease
- Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle, Washington, USA
| | - Deborah J Levine
- Division of Pulmonary and Critical Care Medicine, University of Texas Health, San Antonio, Texas, USA
| | - Karin L Thompson
- Pulmonary Clinical Research Unit, Mayo Clinic, Rochester, Minnesota, USA
| | - Bradley K Johnson
- Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Cassie C Kennedy
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA.,William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|